Spleen tyrosine kinase‑induced JNK‑dependent NLRP3 activation is involved in diabetic cardiomyopathy

  • Authors:
    • Shengyu Li
    • Ruiqing Liu
    • Meiting Xue
    • Yingchun Qiao
    • Yufeng Chen
    • Guangfeng Long
    • Xixi Tian
    • Yahui Hu
    • Pengfei Zhou
    • Xiaohui Dong
    • Zhi Qi
    • Yujie Cui
    • Yanna Shen
  • View Affiliations

  • Published online on: March 27, 2019     https://doi.org/10.3892/ijmm.2019.4148
  • Pages: 2481-2490
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetic cardiomyopathy (DCM) is a leading contributor to the increased morbidity and mortality rates associated with diabetes. Persistent inflammation has previously been reported to be involved in the pathogenesis of DCM. However, the exact underlying molecular mechanisms remain to be fully elucidated. In the present study, the role of spleen tyrosine kinase (Syk) and c‑Jun N‑terminal kinase (JNK) in NLR family pyrin domain‑containing 3 (NLRP3 inflammasome) activation in DCM were investigated in vivo and in vitro. Streptozotocin (65 mg/kg) was injected intraperitoneally into Sprague‑Dawley rats to induce a rat model of diabetes. Neonatal rat cardiomyocytes and H9c2 cells were cultured to detect the expression of JNK, NLRP3 and its associated downstream molecules, following treatment with Syk/JNK inhibitor or Syk/JNK‑small interfering (si)RNA in high glucose (HG) conditions. It was revealed that the protein and mRNA expression levels of phospho (p)‑Syk, p‑JNK, NLRP3 and its associated downstream molecules, including interleukin (IL)‑1β, were upregulated in vivo and in vitro. The JNK inhibitor significantly decreased the expression of NLRP3 and its downstream molecules in neonatal rat cardiomyocytes and H9c2 cells treated with HG. Furthermore, Syk‑siRNA and the Syk inhibitor markedly inhibited the HG‑induced activation of JNK, followed by the downregulation of NLRP3 and its downstream molecules at the mRNA and protein levels in cells. Therefore, it was demonstrated that the HG‑induced activation of NLRP3 was mediated by the activation of Syk/JNK, which subsequently increased the protein expression levels of mature IL‑1β, suggesting that the Syk/JNK/NLRP3 signaling pathway serves a critical role in the pathogenesis of DCM.

References

1 

Whiting DR, Guariguata L, Weil C and Shaw J: IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 94:311–321. 2011. View Article : Google Scholar : PubMed/NCBI

2 

Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K, Sigurdsson G and Rydén L: The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care. 28:612–616. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR and Rodeheffer RJ: Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA. 289:194–202. 2003. View Article : Google Scholar : PubMed/NCBI

4 

Marcinkiewicz A, Ostrowski S and Drzewoski J: Can the onset of heart failure be delayed by treating diabetic cardiomyopathy? Diabetol Metab Syndr. 9:212017. View Article : Google Scholar : PubMed/NCBI

5 

Zhang X, Pan L, Yang K, Fu Y, Liu Y, Chi J, Zhang X, Hong S, Ma X and Yin X: H3 relaxin protects against myocardial injury in experimental diabetic cardiomyopathy by inhibiting myocardial apoptosis, fibrosis and inflammation. Cell Physiol Biochem. 43:1311–1324. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Abdel-Hamid AA and Firgany Ael-D: Atorvastatin alleviates experimental diabetic cardiomyopathy by suppressing apoptosis and oxidative stress. J Mol Histol. 46:337–345. 2015. View Article : Google Scholar : PubMed/NCBI

7 

Niu J, Gilliland MG, Jin Z, Kolattukudy PE and Hoffman WH: MCP-1and IL-1β expression in the myocardia of two young patients with Type 1 diabetes mellitus and fatal diabetic keto-acidosis. Exp Mol Pathol. 96:71–79. 2014. View Article : Google Scholar

8 

Liu Z, Zhao N, Zhu H, Zhu S, Pan S, Xu J, Zhang X, Zhang Y and Wang J: Circulating interleukin-1β promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2. Cardiovasc Diabetol. 14:1252015. View Article : Google Scholar

9 

Westermann D, Rutschow S, Jäger S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M and Tschöpe C: Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: The role of angiotensin type 1 receptor antagonism. Diabetes. 56:641–646. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Zhang X, Fu Y, Li H, Shen L, Chang Q, Pan L, Hong S and Yin X: H3 relaxin inhibits the collagen synthesis via ROS and P2X7R-mediated NLRP3 inflammasome activation in cardiac fibroblasts under high glucose. J Cell Mol Med. 22:1816–1825. 2018. View Article : Google Scholar : PubMed/NCBI

11 

Lee HM, Kim JJ, Kim HJ, Shong M, Ku BJ and Jo EK: Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 62:194–204. 2013. View Article : Google Scholar

12 

Wang C, Pan Y, Zhang QY, Wang FM and Kong LD: Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation. PLoS One. 7:e382852012. View Article : Google Scholar : PubMed/NCBI

13 

Lebreton F, Berishvili E, Parnaud G, Rouget C, Bosco D, Berney T and Lavallard V: NLRP3 inflammasome is expressed and regulated in human islets. Cell Death Dis. 9:7262018. View Article : Google Scholar : PubMed/NCBI

14 

Luo B, Huang F, Liu Y, Liang Y, Wei Z, Ke H, Zeng Z, Huang W and He Y: NLRP3 inflammasome as a molecular marker in diabetic cardiomyopathy. Front Physiol. 8:5192017. View Article : Google Scholar : PubMed/NCBI

15 

Geahlen RL: Getting Syk: Spleen tyrosine kinase as a therapeutic target. Trends Pharmacol Sci. 35:414–422. 2014. View Article : Google Scholar : PubMed/NCBI

16 

Javadov S, Jang S and Agostini B: Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: Therapeutic perspectives. Pharmacol Ther. 144:202–225. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Han MS, Jung DY, Morel C, Lakhani SA, Kim JK, Flavell RA and Davis RJ: JNK expression by macrophages promotes obesity- induced insulin resistance and inflammation. Science. 339:218–222. 2013. View Article : Google Scholar

18 

Kuo WW, Wang WJ, Tsai CY, Way CL, Hsu HH and Chen LM: Diallyl trisufide (DATS) suppresses high glucose-induced cardiomyocyte apoptosis by inhibiting JNK/NFκB signaling via attenuating ROS generation. Int J Cardiol. 168:270–280. 2013. View Article : Google Scholar

19 

Watanabe N, Shikata K, Shikata Y, Sarai K, Omori K, Kodera R, Sato C, Wada J and Makino H: Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. Acta Med Okayama. 65:247–257. 2011.PubMed/NCBI

20 

Yang WS, Chang JW, Han NJ, Lee SK and Park SK: Spleen tyrosine kinase mediates high glucose-induced transforming growth factor-β1 up-regulation in proximal tubular epithelial cells. Exp Cell Res. 318:1867–1876. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Pang A, Hu Y, Zhou P, Long G, Tian X, Men L, Shen Y, Liu Y and Cui Y: Corin is down-regulated and exerts cardioprotective action via activating pro-atrial natriuretic peptide pathway in diabetic cardiomyopathy. Cardiovasc Diabetol. 14:1342015. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

23 

Diamant M, Lamb HJ, Smit JW, de Roos A and Heine RJ: Diabetic cardiomyopathy in uncomplicated type 2 diabetes is associated with the metabolic syndrome and systemic inflammation. Diabetologia. 48:1669–1670. 2005. View Article : Google Scholar : PubMed/NCBI

24 

Pan Y, Wang Y, Zhao Y, Peng K, Li W, Wang Y, Zhang J, Zhou S, Liu Q, Li X, et al: Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy. Diabetes. 63:3497–3511. 2014. View Article : Google Scholar : PubMed/NCBI

25 

Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W and Mu Y: Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. Stem Cell Res Ther. 8:2412017. View Article : Google Scholar : PubMed/NCBI

26 

Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A and Dixit VD: Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology. 152:4039–4045. 2011. View Article : Google Scholar : PubMed/NCBI

27 

Wang C, Zou S, Cui Z, Guo P, Meng Q, Shi X, Gao Y, Yang G and Han Z: Zerumbone protects INS-1 rat pancreatic beta cells from high glucose-induced apoptosis through generation of reactive oxygen species. Biochem Biophys Res Commun. 460:205–209. 2015. View Article : Google Scholar : PubMed/NCBI

28 

Chen J, Mo H, Guo R, You Q, Huang R and Wu K: Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose induced injury in H9c2 cardiac cells. Int J Mol Med. 33:605–612. 2014. View Article : Google Scholar : PubMed/NCBI

29 

Yu Y, Jia XJ, Zhang WP, Fang TT, Hu J, Ma SF and Gao Q: The protective effect of low-dose Ethanol on myocardial fibrosis through downregulating the JNK signaling pathway in diabetic rats. J Diabetes Res. 2016:38342832016. View Article : Google Scholar : PubMed/NCBI

30 

Yan X, Xun M, Li J, Wu L, Dou X and Zheng J: Activation of Na+/K+-ATPase attenuates high glucose-induced H9c2 cell apoptosis via suppressing ROS accumulation and MAPKs activities by DRm217. Acta Biochim Biophys Sin (Shanghai). 48:883–893. 2016. View Article : Google Scholar

31 

Zhou H, Yue Y, Wang J, Ma Q and Chen Y: Melatonin therapy for diabetic cardiomyopathy: A mechanism involving Syk-mitochondrial complex I-SERCA pathway. Cell Signal. 47:88–100. 2018.PubMed/NCBI

32 

Chen YF, Long GF, Tian XX, Qiao YC, Li SY, Xue MT, Liu YD, Cui YJ and Shen YN: Studies on the mechanism of Syk and JNK in the heart tissue of type 1 diabetic rats. Tianjin Med J. 45:463–467. 2017.In Chinese.

33 

Long G, Xue M, Cheb Y, Qiao Y, Tian X, Li S, Liu Y, Shen Y and Cui Y: Effects of Syk on regulation of high glucose-induced apoptosis of H9c2 myocardial cells and its mechanism. Int J Endocrinol Metabolism. 37:303–307. 2017.

34 

Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, Zhuang Y, Cai T, Wang F and Shao F: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature. 526:660–665. 2015.PubMed/NCBI

35 

Kovacs SB and Miao EA: Gasdermins: Effectors of pyroptosis. Trends Cell Biol. 27:673–684. 2017.PubMed/NCBI

36 

Liu Z, Gan L, Xu Y, Luo D, Ren Q, Wu S and Sun C: Melatonin alleviates inflammasome-induced pyroptosis through inhibiting NF-κB/GSDMD signal in mice adipose tissue. J Pineal Res. 63:2017.

Related Articles

Journal Cover

June 2019
Volume 43 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, S., Liu, R., Xue, M., Qiao, Y., Chen, Y., Long, G. ... Shen, Y. (2019). Spleen tyrosine kinase‑induced JNK‑dependent NLRP3 activation is involved in diabetic cardiomyopathy. International Journal of Molecular Medicine, 43, 2481-2490. https://doi.org/10.3892/ijmm.2019.4148
MLA
Li, S., Liu, R., Xue, M., Qiao, Y., Chen, Y., Long, G., Tian, X., Hu, Y., Zhou, P., Dong, X., Qi, Z., Cui, Y., Shen, Y."Spleen tyrosine kinase‑induced JNK‑dependent NLRP3 activation is involved in diabetic cardiomyopathy". International Journal of Molecular Medicine 43.6 (2019): 2481-2490.
Chicago
Li, S., Liu, R., Xue, M., Qiao, Y., Chen, Y., Long, G., Tian, X., Hu, Y., Zhou, P., Dong, X., Qi, Z., Cui, Y., Shen, Y."Spleen tyrosine kinase‑induced JNK‑dependent NLRP3 activation is involved in diabetic cardiomyopathy". International Journal of Molecular Medicine 43, no. 6 (2019): 2481-2490. https://doi.org/10.3892/ijmm.2019.4148